Keryx Biopharm Inc (KERX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Sales | 0 | 0 | 7,000 | 0 | 0 |
| Gross Profit | N/A | N/A | 7,000 | N/A | N/A |
| Operating Expenses | 15,732 | 11,454 | 9,158 | 6,678 | 5,526 |
| Operating Income | -15,732 | -11,454 | -2,158 | -6,678 | -5,526 |
| Other Income | 81 | 96 | 103 | 50 | 51 |
| Pre-tax Income | -15,651 | -11,358 | -2,055 | -6,628 | -5,475 |
| Net Income Continuous | -15,651 | -11,358 | -2,055 | -6,628 | -5,475 |
| Net Income | $-15,651 | $-11,358 | $-2,055 | $-6,628 | $-5,475 |
| EPS Basic Total Ops | -0.19 | -0.14 | -0.03 | -0.09 | -0.08 |
| EPS Basic Continuous Ops | -0.19 | -0.14 | -0.03 | -0.10 | -0.08 |
| EPS Diluted Total Ops | -0.19 | -0.14 | -0.03 | -0.09 | -0.08 |
| EPS Diluted Continuous Ops | -0.19 | -0.14 | -0.03 | -0.10 | -0.08 |
| EBITDA(a) | $-15,720 | $-11,442 | $-2,148 | $-6,670 | $-5,518 |